Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1985 Mar;53(3):237–239. doi: 10.1136/hrt.53.3.237

Coronary artery bypass grafting and hyperlipidaemia.

G Thompson, R Sapsford
PMCID: PMC481748  PMID: 3871620

Full text

PDF
237

Images in this article

238Image
on p.238

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allard C., Ruscito O., Goulet C. The influence of serum triglycerides on the fate of aorto-coronary vein grafts. Can Med Assoc J. 1972 Aug 5;107(3):213–216. [PMC free article] [PubMed] [Google Scholar]
  2. Banks D. C., Raftery E. B., Oram S. Clinical significance of the coronary arteriogram. Br Heart J. 1971 Nov;33(6):863–870. doi: 10.1136/hrt.33.6.863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barboriak J. J., Batayias G. E., Pintar K., Korns M. E. Pathological changes in surgically removed aortocoronary vein grafts. Ann Thorac Surg. 1976 Jun;21(6):524–527. doi: 10.1016/s0003-4975(10)63922-7. [DOI] [PubMed] [Google Scholar]
  4. Barboriak J. J., Pintar K., Korns M. E. Atherosclerosis in aortocoronary vein grafts. Lancet. 1974 Sep 14;2(7881):621–624. doi: 10.1016/s0140-6736(74)91945-x. [DOI] [PubMed] [Google Scholar]
  5. Bemis C. E., Gorlin R., Kemp H. G., Herman M. V. Progression of coronary artery disease. A clinical arteriographic study. Circulation. 1973 Mar;47(3):455–464. doi: 10.1161/01.cir.47.3.455. [DOI] [PubMed] [Google Scholar]
  6. Bloch A., Dinsmore R. E., Lees R. S. Coronary arteriographic findings in type-II and type-IV hyperlipoproteinaemia. Lancet. 1976 May 1;1(7966):928–930. doi: 10.1016/s0140-6736(76)92711-2. [DOI] [PubMed] [Google Scholar]
  7. Brensike J. F., Levy R. I., Kelsey S. F., Passamani E. R., Richardson J. M., Loh I. K., Stone N. J., Aldrich R. F., Battaglini J. W., Moriarty D. J. Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study. Circulation. 1984 Feb;69(2):313–324. doi: 10.1161/01.cir.69.2.313. [DOI] [PubMed] [Google Scholar]
  8. Brower R. W., Laird-Meeter K., Serruys P. W., Meester G. T., Hugenholtz P. G. Long term follow-up after coronary artery bypass graft surgery. Progression and regression of disease in native coronary circulation and bypass grafts. Br Heart J. 1983 Jul;50(1):42–47. doi: 10.1136/hrt.50.1.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Campeau L., Enjalbert M., Lespérance J., Bourassa M. G., Kwiterovich P., Jr, Wacholder S., Sniderman A. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N Engl J Med. 1984 Nov 22;311(21):1329–1332. doi: 10.1056/NEJM198411223112101. [DOI] [PubMed] [Google Scholar]
  10. Chesebro J. H., Fuster V., Elveback L. R., Clements I. P., Smith H. C., Holmes D. R., Jr, Bardsley W. T., Pluth J. R., Wallace R. B., Puga F. J. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med. 1984 Jan 26;310(4):209–214. doi: 10.1056/NEJM198401263100401. [DOI] [PubMed] [Google Scholar]
  11. Cohn P. F., Gabbay S. I., Weglicki W. B. Serum lipid levels in angiographically defined coronary artery disease. Ann Intern Med. 1976 Mar;84(3):241–245. doi: 10.7326/0003-4819-84-3-241. [DOI] [PubMed] [Google Scholar]
  12. Detre K., Murphy M. L., Hultgren H. Effect of coronary bypass surgery on longevity in high and low risk patients. Report from the V.A. Cooperative Coronary Surgery Study. Lancet. 1977 Dec 17;2(8051):1243–1245. doi: 10.1016/s0140-6736(77)92659-9. [DOI] [PubMed] [Google Scholar]
  13. Favaloro R. G. Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique. Ann Thorac Surg. 1968 Apr;5(4):334–339. doi: 10.1016/s0003-4975(10)66351-5. [DOI] [PubMed] [Google Scholar]
  14. Frick M. H., Dahlén G., Berg K., Valle M., Hekali P. Serum lipids in angiographically assessed coronary atherosclerosis. Chest. 1978 Jan;73(1):62–65. doi: 10.1378/chest.73.1.62. [DOI] [PubMed] [Google Scholar]
  15. Gotto A. M., Gorry G. A., Thompson J. R., Cole J. S., Trost R., Yeshurun D., DeBakey M. E. Relationship between plasma lipid concentrations and coronary artery disease in 496 patients. Circulation. 1977 Nov;56(5):875–883. doi: 10.1161/01.cir.56.5.875. [DOI] [PubMed] [Google Scholar]
  16. Heinle R. A., Levy R. I., Frederickson D. S., Gorlin R. Lipid and carbohydrate abnormalities in patients with angiographically documented coronary artery disease. Am J Cardiol. 1969 Aug;24(2):178–186. doi: 10.1016/0002-9149(69)90401-9. [DOI] [PubMed] [Google Scholar]
  17. Jenkins P. J., Harper R. W., Nestel P. J. Severity of coronary atherosclerosis related to lipoprotein concentration. Br Med J. 1978 Aug 5;2(6134):388–391. doi: 10.1136/bmj.2.6134.388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kolata G. B. Coronary bypass surgery: debate over its benefits. Science. 1976 Dec 11;194(4271):1263–1265. doi: 10.1126/science.194.4271.1263. [DOI] [PubMed] [Google Scholar]
  19. Lawrie G. M., Morris G. C., Jr, Howell J. F., Tredici T. D., Chapman D. W. Improved survival after 5 years in 1,144 patients after coronary bypass surgery. Am J Cardiol. 1978 Nov;42(5):709–715. doi: 10.1016/0002-9149(78)90088-7. [DOI] [PubMed] [Google Scholar]
  20. Levy R. I., Brensike J. F., Epstein S. E., Kelsey S. F., Passamani E. R., Richardson J. M., Loh I. K., Stone N. J., Aldrich R. F., Battaglini J. W. The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study. Circulation. 1984 Feb;69(2):325–337. doi: 10.1161/01.cir.69.2.325. [DOI] [PubMed] [Google Scholar]
  21. Lie J. T., Lawrie G. M., Morris G. C., Jr Aortocoronary bypass saphenous vein graft atherosclerosis. Anatomic study of 99 vein grafts from normal and hyperlipoproteinemic patients up to 75 months postoperatively. Am J Cardiol. 1977 Dec;40(6):906–914. doi: 10.1016/0002-9149(77)90041-8. [DOI] [PubMed] [Google Scholar]
  22. Lorenz R. L., Schacky C. V., Weber M., Meister W., Kotzur J., Reichardt B., Theisen K., Weber P. C. Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily). Effects on platelet aggregation and thromboxane formation. Lancet. 1984 Jun 9;1(8389):1261–1264. doi: 10.1016/s0140-6736(84)92446-2. [DOI] [PubMed] [Google Scholar]
  23. Miller N. E., Hammett F., Saltissi S., Rao S., van Zeller H., Coltart J., Lewis B. Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. Br Med J (Clin Res Ed) 1981 May 30;282(6278):1741–1744. doi: 10.1136/bmj.282.6278.1741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Murray R. G., Tweddel A., Third J. L., Hutton I., Hillis W. S., Lorimer A. R., Lawrie T. D. Relation between extent of coronary artery disease and severity of hyperlipoproteinaemia. Br Heart J. 1975 Dec;37(12):1205–1209. doi: 10.1136/hrt.37.12.1205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Nash D. T., Gensini G., Simon H., Arno T., Nash S. D. The Erysichthon syndrome. Progression of coronary atherosclerosis and dietary hyperlipidemia. Circulation. 1977 Sep;56(3):363–365. doi: 10.1161/01.cir.56.3.363. [DOI] [PubMed] [Google Scholar]
  26. Pantely G. A., Goodnight S. H., Jr, Rahimtoola S. H., Harlan B. J., DeMots H., Calvin L., Rösch J. Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study. N Engl J Med. 1979 Nov 1;301(18):962–966. doi: 10.1056/NEJM197911013011803. [DOI] [PubMed] [Google Scholar]
  27. Simpson H. C., Mann J. I., Meade T. W., Chakrabarti R., Stirling Y., Woolf L. Hypertriglyceridaemia and hypercoagulability. Lancet. 1983 Apr 9;1(8328):786–790. doi: 10.1016/s0140-6736(83)91849-4. [DOI] [PubMed] [Google Scholar]
  28. Sugrue D. D., Thompson G. R., Oakley C. M., Trayner I. M., Steiner R. E. Contrasting patterns of coronary atherosclerosis in normocholesterolaemic smokers and patients with familial hypercholesterolaemia. Br Med J (Clin Res Ed) 1981 Nov 21;283(6303):1358–1360. doi: 10.1136/bmj.283.6303.1358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Thompson G. Apoproteins: determinants of lipoprotein metabolism and indices of coronary risk. Br Heart J. 1984 Jun;51(6):585–588. doi: 10.1136/hrt.51.6.585. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES